Evidence map›Paper›PMID 30061325›Full record

ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2018

How placebo characteristics can influence estimates of intervention effects in trials.

Jeremy Howick, Tammy Hoffmann

Abstract read
In one paragraph

Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Impact of a Chokeberry (Nutrients · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Risk factors associated with nocebo effects: A review of reviews.Brain, behavior, & immunity - health · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. [Biosimilars and the nocebo effect].Zeitschrift fur Rheumatologie · 2020
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jeremy HowickNuffield Department of Primary Care Health Sciences (Howick), University of Oxford, UK; Centre for Research in Evidence-Based Practice (Hoffmann), Faculty of Health Sciences and Medicine, Bond University, Robina, Queensland, Australia Jeremy.howick@phc.ox.ac.uk.
Tammy HoffmannNuffield Department of Primary Care Health Sciences (Howick), University of Oxford, UK; Centre for Research in Evidence-Based Practice (Hoffmann), Faculty of Health Sciences and Medicine, Bond University, Robina, Queensland, Australia.

Funding

Medical Research Council G0800055
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ChecklistData Interpretation, StatisticalHumansPlacebosRandomized Controlled Trials as TopicSystematic Reviews as TopicPlacebos

Identifiers

PMID30061325
PMCPMC6066403

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.